Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 7/17/25 → 7/17/27 |
Financiación
- Crinetics Pharmaceuticals: 64.019,00 US$
25-NET-02-CPI (CRN00808-12): A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors
- Anthony, Lowell (PI)